Two Sigma Securities, LLC Precigen, Inc. Transaction History

Two Sigma Securities, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.89 - $1.41 $30,095 - $47,679	33,815 Added 267.44%	46,459 $62,000
Q3 2023 Nov 14, 2023	BUY	$1.08 - $1.85 $13,655 - $23,391	12,644 New	12,644 $17,000
Q1 2023 May 15, 2023	BUY	$0.88 - $2.19 $20,606 - $51,281	23,416 New	23,416 $24,000
Q2 2022 Aug 15, 2022	BUY	$1.15 - $2.53 $13,000 - $28,601	11,305 New	11,305 $15,000
Q1 2022 May 16, 2022	SELL	$1.91 - $3.98 $33,455 - $69,713	-17,516 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.53 - $5.5 $61,831 - $96,338	17,516 New	17,516 $65,000

143

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $175M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.